Advertisement

Advertisement

AU:TLX Stock Latest News

Telix to Release Escrowed Shares from Lightpoint Acquisition

Company AnnouncementsTelix to Release Escrowed Shares from Lightpoint Acquisition

Telix to Spotlight Next‑Generation PSMA Therapy Portfolio in Investor Webinar

PremiumCompany Announcements

Telix to Spotlight Next‑Generation PSMA Therapy Portfolio in Investor Webinar

7d ago

Telix Pharmaceuticals Issues New Tranche of Unquoted Convertible Notes

PremiumCompany Announcements

Telix Pharmaceuticals Issues New Tranche of Unquoted Convertible Notes

12d ago

Telix Reshapes Capital Structure With US$600m Convertible Issue and Bond Buyback

PremiumCompany Announcements

Telix Reshapes Capital Structure With US$600m Convertible Issue and Bond Buyback

12d ago

Telix Sets Hybrid 2026 AGM to Engage Global Investor Base

PremiumCompany Announcements

Telix Sets Hybrid 2026 AGM to Engage Global Investor Base

14d ago

Telix raises US$600m via new convertible notes to refinance 2029 bonds

PremiumCompany AnnouncementsTelix raises US$600m via new convertible notes to refinance 2029 bonds

15d ago

Telix Issues New Unquoted Share Rights Under Employee Incentive Scheme

Company Announcements

Telix Issues New Unquoted Share Rights Under Employee Incentive Scheme

18d ago

Telix Reports Lapse of Share Appreciation and Performance Rights

Company Announcements

Telix Reports Lapse of Share Appreciation and Performance Rights

18d ago

Telix Pharmaceuticals Files Appendix 3B for Proposed Securities Issue

PremiumCompany Announcements

Telix Pharmaceuticals Files Appendix 3B for Proposed Securities Issue

20d ago

Telix Upsizes US$600m Convertible Bond to Refinance 2029 Notes

PremiumCompany Announcements

Telix Upsizes US$600m Convertible Bond to Refinance 2029 Notes

20d ago

Telix Pharmaceuticals: Balance Sheet De-Risking and Clinical Momentum Support Further Upside and Buy Rating

PremiumRatings

Telix Pharmaceuticals: Balance Sheet De-Risking and Clinical Momentum Support Further Upside and Buy Rating

20d ago

Telix Showcases Glioblastoma Case Response and Details Offshore Convertible Bond Offer

PremiumCompany Announcements

Telix Showcases Glioblastoma Case Response and Details Offshore Convertible Bond Offer

20d ago

Telix Raises US$550m in Convertible Note Refi to Extend Debt Maturity

PremiumCompany AnnouncementsTelix Raises US$550m in Convertible Note Refi to Extend Debt Maturity

21d ago

Telix and Regeneron Strike Global Radiopharma Alliance in Precision Oncology Push

Company Announcements

Telix and Regeneron Strike Global Radiopharma Alliance in Precision Oncology Push

22d ago

Citi Group Entities Drop Below Substantial Holder Threshold in Telix Pharmaceuticals

Company Announcements

Citi Group Entities Drop Below Substantial Holder Threshold in Telix Pharmaceuticals

25d ago

FDA Accepts Telix NDA for Glioma Imaging Agent TLX101-Px

PremiumCompany Announcements

FDA Accepts Telix NDA for Glioma Imaging Agent TLX101-Px

25d ago

Telix Issues 10,000 New Shares Following Conversion of Unquoted Securities

PremiumCompany Announcements

Telix Issues 10,000 New Shares Following Conversion of Unquoted Securities

26d ago

Telix Seeks ASX Quotation for Additional Ordinary Shares

PremiumCompany Announcements

Telix Seeks ASX Quotation for Additional Ordinary Shares

26d ago

PremiumCompany Announcements

Telix Adds High-Profile Directors to Bolster Global Biopharma Push

26d ago

Challenger Exits Substantial Holder Position in Telix Pharmaceuticals

PremiumCompany AnnouncementsChallenger Exits Substantial Holder Position in Telix Pharmaceuticals

28d ago

Telix boosts Q1 revenue and advances global radiopharma pipeline

Company Announcements

Telix boosts Q1 revenue and advances global radiopharma pipeline

28d ago

Citi Group Entities Exit Substantial Holder Status in Telix Pharmaceuticals

Company Announcements

Citi Group Entities Exit Substantial Holder Status in Telix Pharmaceuticals

1M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >